Trump Bought Up to $5M in Taser Stock Weeks Before ICE Sought a $220M Taser Deal.

President Trump disclosed buying between $1 million and $5 million in stock in Axon Enterprise, the maker of Tasers, on February 10, 2026. Two weeks later, his own Immigration and Customs Enforcement posted a notice seeking up to $220 million in stun weapons, with specifications that procurement experts say match Axon’s products and would shut out other vendors, CNBC reported. The White House says there is “no conflict of interest.”

The Timeline

The dates are the story. Trump’s purchase of Axon stock appears in his federal financial disclosure, dated February 10, 2026, in the range of $1 million to $5 million.

On about February 24, ICE posted a solicitation for a five-year purchase worth roughly $220 million, covering about 17,800 conductive-energy weapons along with cartridges, training, and support. When the timeline was widely reported in late June, Axon’s stock jumped roughly 10%.

A Contract Shaped Like Axon

Procurement and policing experts who reviewed the ICE notice told reporters its specifications line up closely with Axon’s products, down to details like the weapon’s range, its probe count, and references to a “T-10,” the name of Axon’s Taser 10. Those specs, they said, would likely preclude other vendors from competing.

“The concern is that he bought into a company whose business could grow if his own administration expands immigration enforcement.”

Jordan Libowitz, Citizens for Responsibility and Ethics in Washington

Axon dominates the U.S. market for police stun weapons. A federal solicitation written around its exact product line is, in effect, an order only Axon can fill.

What Is Established, and What Is Not

The timeline is documented. What it proves, and what it does not, are two different things, and the difference matters.

Established: the purchase date and dollar range are in federal disclosures. The ICE notice and its roughly $220 million value are public. Experts have said on the record that the specifications map to Axon’s products.

Not established: there is no public evidence that Trump directed the procurement or knew about it, that ICE contracting officials knew about his stake, or that Axon knew he had bought in. No contract has been awarded.

The ICE posting was a solicitation, an early step, and there is no public record yet of responses or an award. The conflict here is structural and documented. Intent is not.

The White House defense rests on a trust. It says the president’s investments are held in a trust managed by his children, with independent firms making the trades, so he has no conflict.

That is not what a blind trust is. The federal Office of Government Ethics has said for years that handing operational control to your own children “would not constitute the establishment of a qualified blind trust, nor would it eliminate conflicts of interest.” A real blind trust means the official does not know what he owns. Trump knows he owns Axon, because the law made him disclose it.

A Conflict Law That Skips the President

There is a federal criminal law, 18 U.S.C. § 208, that bars officials from acting on matters where they hold a financial interest. It does not apply to the president. A 1974 Justice Department opinion exempted the office, and Congress wrote the exemption into law in 1989.

That exemption is exactly why the ethics office has long urged presidents to act as if the law bound them, by divesting or using a true blind trust. Every modern president did, until this one. The emoluments clauses were meant to be a backstop against presidential self-enrichment, but no court has been willing to enforce them.

Why It Matters

Strip away the question of intent and a plain structural problem remains. The one official with the most power over a $220 million federal contract is the one official the conflict-of-interest law exempts, holding up to $5 million in the company best positioned to win it.

For 50 years, the gap in the law was filled by a norm. Presidents gave up control of their holdings so no one had to wonder whether policy was being made for the country or for the portfolio. That norm is the thing being discarded here, and a solicitation for 17,800 Tasers is what it looks like when it goes.

What You Can Do Now

Use the letter below to ask your members of Congress to open an oversight investigation into the timing of the stock purchase and the ICE solicitation, including whether the contract specifications were written to fit a single company.
Call your senators and representative at (202) 224-3121. Ask them to pass the Presidential Conflicts of Interest Act, which would require the president to divest or use a qualified blind trust like other officials.
Watch for the award. The ICE notice is still a solicitation. If a contract goes to Axon while the president holds the stock, that is the moment to call again and demand answers.